Wednesday, July 8, 2026

pharma · Non-Hodgkin Lymphoma · Advanced Solid Tumors · ADCT

ADC Therapeutics

NovaPharmaNews editorial coverage mentioning ADC Therapeutics — regulatory, clinical, and market analysis.

Lausanne, Vaud, Switzerland, CH HQ
2011 Founded
272 Employees
Public company Type
ADCT · NYSE Ticker
Company details
Status
Public
HQ
Lausanne, Vaud, Switzerland, CH
Founded
2011
Employees
272
Programs
30
Drugs
15
Patents
22
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning ADC Therapeutics — regulatory, clinical, and market coverage.

NovaPharmaNews editorial coverage mentioning ADC Therapeutics — regulatory, clinical, and market analysis.

No coverage yet

We have not published news or analysis mentioning ADC Therapeutics yet.

Back to company overview →